Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide)

Qin Shi,Jie Zhang,Chen Zhang,Jing Jiang,Jun Tao,Dongshan Zhou,Ting Cai

DOI: https://doi.org/10.1021/acs.molpharmaceut.7b00854

2017-01-01

Molecular Pharmaceutics

Abstract:Physical stability of pharmaceutical amorphous solid dispersions is one of the critical attributes to the successful development of the formulation. Herein, we studied the impact of low-concentration poly(ethylene oxide) (PEO) on the crystallization rates of three polymorphs of indomethacin (IMC, gamma-, alpha-, and delta-form). We observed that the addition of 3% w/w PEO significantly increased the crystal growth rates of gamma-form and alpha-form of IMC, but had a negligible effect on the delta-form. The reduction of the activation energy for the crystal growth of IMC polymorphs after adding the PEO follows the order gamma-form > alpha-form > alpha-form, which is consistent with the trend toward the accelerating effects of PEO on the crystal growth rates of three polymorphs. With the addition of low-concentration PEO, there is an increase of molecular mobility of IMC as evidenced by the decreased structural relaxation times and viscosities. This study suggests that the substantially different effects of PEO on the crystal growth rates of IMC polymorphs are attributable to the different adsorption of PEO on the crystal surface of those polymorphs, which in turn exerts a selective accelerating effect on IMC molecules to organize into the different crystalline phases. These findings are relevant for understanding the crystallization behavior of amorphous solid dispersions containing polymorphic drugs.